Theratechnologies Inc.
TH.TO
TSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.23% | 6.61% | 8.37% | 25.46% | -18.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.23% | 6.61% | 8.37% | 25.46% | -18.39% |
| Cost of Revenue | -34.08% | 20.33% | -8.98% | -7.37% | 12.59% |
| Gross Profit | 41.97% | 2.83% | 13.79% | 38.21% | -27.95% |
| SG&A Expenses | 13.14% | 44.19% | -11.34% | -7.24% | -16.06% |
| Depreciation & Amortization | -- | -42.70% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.25% | 27.97% | -21.22% | -26.53% | -26.95% |
| Operating Income | 184.37% | -80.16% | 11,405.56% | 141.39% | 58.46% |
| Income Before Tax | 109.70% | -156.60% | 720.48% | 111.18% | 57.76% |
| Income Tax Expenses | 179.09% | 1,298.63% | 500.00% | -6.35% | 14.58% |
| Earnings from Continuing Operations | 102.61% | -186.86% | 514.34% | 109.86% | 57.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.61% | -186.86% | 514.34% | 109.86% | 57.09% |
| EBIT | 184.37% | -80.16% | 11,405.56% | 141.39% | 58.46% |
| EBITDA | 227.36% | -74.13% | 688.80% | 162.95% | 60.33% |
| EPS Basic | 102.64% | -90.14% | 303.25% | 104.83% | 78.96% |
| Normalized Basic EPS | 119.35% | -478.79% | 404.38% | 105.48% | 72.61% |
| EPS Diluted | 102.30% | -90.14% | 294.81% | 104.83% | 76.83% |
| Normalized Diluted EPS | 118.99% | -478.79% | 404.38% | 105.48% | 72.61% |
| Average Basic Shares Outstanding | 0.00% | 50.84% | 103.96% | 103.96% | 103.96% |
| Average Diluted Shares Outstanding | 2.10% | 50.84% | 104.00% | 103.99% | 103.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |